# SCRIMED Pilot Demo Commercial Readiness Brief

Status: pilot-demo-commercial-accelerator-active
Updated: 2026-06-26
Demos: 6
Pilots: 4
Demo offer paths: 6
Buyer conversion packets: 6
Market benchmarks: 7
Pricing alignments: 6
Standard path score: 100%

## Boundary
SCRIMED Pilot Demo Commercial Readiness turns demos, pilot programs, pricing tiers, market benchmarks, proof routes, onboarding steps, and margin controls into a seamless no-PHI buyer path. It is commercial readiness and pricing guidance only. It does not create a signed quote, contract, legal advice, accounting advice, tax advice, audited financial reporting, securities material, investment advice, valuation assurance, revenue guarantee, profit guarantee, ROI guarantee, reimbursement guarantee, customer permission, procurement approval, security certification, PHI processing authority, production connector approval, EHR writeback approval, payer submission approval, or live clinical care authorization.

This brief is not a signed quote, contract, legal advice, accounting advice, tax advice, audited financial reporting, securities material, investment advice, valuation assurance, revenue guarantee, profit guarantee, ROI guarantee, reimbursement guarantee, customer permission, procurement approval, security certification, PHI processing authority, production connector approval, EHR writeback approval, payer submission approval, or live clinical care authorization.

## Recommended Market Position
SCRIMED should use free self-guided demos to compete with low-friction AI scribe entry, then price paid work as enterprise workflow intelligence, governance, interoperability readiness, proof packaging, and protected pilot infrastructure.

## Pricing Decision
Keep public demos free, guided standard demos no-cost for qualified buyers, assessments at $25k-$150k depending on scope, synthetic pilots at $125k-$500k, protected pilots at $400k-$2M+, annual licenses at $1.5M-$12M+, and strategic partnerships at $8M-$25M+.

## Seamless Conversion Steps
1. Choose the buyer problem: buyer Select the closest demo from access, documentation, research, interoperability, or AgentOS governance. SCRIMED Route the buyer to a single demo path with proof assets, success questions, and blocked claims. Proof: /demos. Pricing: Free public preview; no custom work starts here.. Boundary: No PHI, patient identifiers, production credentials, or customer claims.
2. Run the proof path: buyer Inspect the executable surface, result route, and downloadable demo brief. SCRIMED Keep proof one click away and convert questions into a recommended package. Proof: /pilot-demo-commercial-readiness. Pricing: Guided demo is free for qualified buyers; custom demo prep becomes paid diligence.. Boundary: Demo proof is synthetic and does not show clinical validation or production authorization.
3. Match the pilot package: buyer Pick a 30-day sprint, 45-90 day synthetic pilot, or protected enterprise planning path. SCRIMED Attach recommended price band, scope cap, owner map, and buyer inputs before intake. Proof: /pilots. Pricing: Package price band is shown before custom SOW expansion.. Boundary: Final quote, SOW, payment terms, and buyer approval require human review.
4. Submit no-PHI intake: buyer Provide organization, sponsor, workflow, timeline, and governance context without patient data. SCRIMED Convert intake into CRM-safe follow-up, onboarding stage, and service-delivery handoff. Proof: /pilot. Pricing: No unpaid implementation or security questionnaire work before package selection.. Boundary: Intake is not contract approval, procurement approval, or PHI authorization.
5. Open buyer deal room: buyer Review proof packet needs, diligence lane, pricing posture, security questions, and next decision. SCRIMED Route custom proof, release review, evidence-room work, and procurement support as paid scope. Proof: /pilot-deal-room. Pricing: Paid diligence or activation retainer protects margin before enterprise proof work expands.. Boundary: No external distribution, customer permission, security certification, or production approval implied.
6. Kick off scoped delivery: buyer Approve package, owners, cadence, acceptance criteria, and boundaries. SCRIMED Move into service delivery with artifacts, gates, hard stops, and escalation rules. Proof: /service-delivery. Pricing: Implementation, connectors, support, and review retainers stay separate from license fees.. Boundary: Delivery work is not an SLA, live-care authorization, or production connector approval.

## Demo Offer Paths
- CarePath Access Operations Demo: recommend 60-Day Governed Automation Pilot ($125k-$350k for 45-90 days after sponsor and workflow owner are confirmed.). CTA: /pilot?offer=synthetic-pilot-evaluation&demo=carepath-access-operations. Boundary: No autonomous outreach, diagnosis, treatment, emergency routing, PHI, or live workflow execution.
- DocuTwin Documentation Review Demo: recommend 60-Day Governed Automation Pilot ($125k-$350k standard; custom note-quality, source-trace, or specialty packet work priced separately.). CTA: /pilot?offer=synthetic-pilot-evaluation&demo=docutwin-documentation-review. Boundary: No final note, EHR filing, diagnosis insertion, autonomous documentation, PHI, or clinical validation claim.
- PayerIQ Documentation Readiness Demo: recommend 60-Day Governed Automation Pilot ($125k-$350k for a governed synthetic documentation-readiness pilot; buyer-specific policy mapping is separately scoped.). CTA: /pilot?offer=synthetic-pilot-evaluation&demo=prior-authorization-support. Boundary: No live PHI, medical-necessity determination, payer submission, appeal filing, EHR writeback, or reimbursement guarantee.
- TrialCore Research Operations Demo: recommend 60-Day Governed Automation Pilot ($125k-$350k standard; research-network or multi-study scope requires custom pricing.). CTA: /pilot?offer=synthetic-pilot-evaluation&demo=trialcore-research-operations. Boundary: No patient outreach, enrollment decision, treatment recommendation, PHI, or production research-record mutation.
- Atlas Interoperability Readiness Demo: recommend AI Governance + Interoperability Readiness Pilot ($75k-$225k for readiness; production connector work requires separate reviewed scope.). CTA: /pilot?offer=interoperability-readiness-sprint&demo=atlas-interoperability-readiness. Boundary: No live healthcare data exchange, connector certification, trading-partner acceptance, or production mutation.
- AgentOS Governance Evaluation Demo: recommend AI Governance + Interoperability Readiness Pilot ($75k-$225k for governance and interoperability readiness; protected pilot scope starts above this.). CTA: /pilot?offer=trustos-ai-governance-audit&demo=agentos-governance-evaluation. Boundary: No live PHI ingestion, autonomous clinical execution, production connector access, or payer/patient action.

## Buyer Conversion Packets
- CarePath Access Operations Demo: sponsor=VP Access, Chief Operating Officer, or Population Health leader; owner=Access operations manager or care coordination director; paid step=Synthetic Pilot Evaluation; guardrail=$125k-$350k for 45-90 days after sponsor and workflow owner are confirmed.; close=Confirm one access workflow, sponsor, reviewer role, price band, and no-PHI intake before opening scoped pilot work.; audit=scrimed-intel-fcbde5ee
- DocuTwin Documentation Review Demo: sponsor=CMIO, documentation improvement leader, ambulatory operations leader, or quality executive; owner=Clinical documentation manager or physician champion; paid step=Synthetic Pilot Evaluation; guardrail=$125k-$350k standard; custom note-quality, source-trace, or specialty packet work priced separately.; close=Convert the buyer to a governed documentation pilot with capped note fixtures, reviewer role, and source-trace acceptance criteria.; audit=scrimed-intel-9154add2
- PayerIQ Documentation Readiness Demo: sponsor=VP Revenue Cycle, prior authorization director, utilization-management leader, or CFO transformation sponsor; owner=Prior authorization operations manager or RCM documentation lead; paid step=Synthetic Pilot Evaluation; guardrail=$125k-$350k for a governed synthetic documentation-readiness pilot; buyer-specific policy mapping is separately scoped.; close=Scope one procedure family, synthetic requirement set, reviewer role, buyer baseline, price band, and no-submission acceptance criteria.; audit=scrimed-intel-6f774598
- TrialCore Research Operations Demo: sponsor=Research operations leader, oncology program leader, or clinical trials executive; owner=Trial operations manager or protocol-review lead; paid step=Synthetic Pilot Evaluation; guardrail=$125k-$350k standard; research-network or multi-study scope requires custom pricing.; close=Scope a research-operations pilot around criteria trace, reviewer queue, evidence gaps, and no-PHI fixtures.; audit=scrimed-intel-62c681ba
- Atlas Interoperability Readiness Demo: sponsor=CIO, integration leader, digital health executive, or platform owner; owner=FHIR, HL7, or integration architecture lead; paid step=Interoperability Readiness Sprint; guardrail=$75k-$225k for readiness; production connector work requires separate reviewed scope.; close=Move to a standards-readiness sprint with one data-family target, proof route, owner, and connector-boundary memo.; audit=scrimed-intel-9c58c6b5
- AgentOS Governance Evaluation Demo: sponsor=Chief AI officer, compliance executive, innovation leader, or clinical transformation leader; owner=AI governance program owner or compliance reviewer; paid step=TrustOS AI Governance Audit; guardrail=$75k-$225k for governance and interoperability readiness; protected pilot scope starts above this.; close=Convert to a governance audit with inventory scope, policy stack, reviewer role, and no-production-authority boundary.; audit=scrimed-intel-dc835f43

## Pricing Tier Alignment
- Public Product Preview: Free, self-guided, no-PHI, no account required; qualified guided demo stays no-cost when it is standard.. Rationale: Freed, Tali, and Heidi show that healthcare AI buyers expect a low-friction entry path before enterprise review.. Margin rule: Keep standard demo labor capped; move custom demo prep, questionnaires, and buyer-specific proof packets into paid diligence.
- Workflow Intelligence Assessment: $25k-$75k standard; $12.5k-$25k mission clinic access path for one no-PHI workflow; $75k-$150k for multi-workflow enterprise assessment.. Rationale: Individual scribe subscriptions are cheap, but enterprise assessment value sits in workflow redesign, governance, interoperability, and executive decision support.. Margin rule: Cap workflows, meetings, artifacts, and review cycles; discount only by reducing scope.
- Synthetic Pilot Evaluation: $125k-$350k standard for 45-90 days; $350k-$500k when multiple workflows, extra diligence, or executive proof packets are included.. Rationale: Enterprise AI workflow pilots should sit well above seat-based scribe tools while staying below production integration commitments.. Margin rule: Limit workflow count and evidence cadence; separately price custom data modeling, legal/security packet labor, and implementation planning.
- Protected Enterprise Pilot: $400k-$1.25M for 90-180 days; $1.25M-$2M+ when buyer-specific protected diligence, sandbox planning, or multi-site scope expands.. Rationale: Redox and enterprise AI vendors use custom pricing because integration, security, governance, reliability, and implementation scope drive cost.. Margin rule: Separate license, services, support, connectors, evidence-room labor, customer success, and change orders.
- Enterprise Operating License: $1.5M-$6M annual for initial enterprise operating layer; $6M-$12M+ for multi-department or multi-region expansion.. Rationale: Ambience, Suki, Redox, and similar enterprise motions compete on workflow breadth, EHR adjacency, trust, uptime, data exchange, and measurable operational outcomes.. Margin rule: Annual license is separate from implementation services, model usage, support tier, connector work, and continuous review retainer.
- Strategic Platform Partnership: $8M-$25M+ multi-year, sales-led, region-aware, and external-review-gated.. Rationale: National, payer, sovereign, and platform partnerships are not scribe subscriptions; they are multi-stakeholder infrastructure and governance programs.. Margin rule: Regional legal, tax, hosting, support, partner economics, and certification work require separate review.

## Market Benchmarks
- Freed (Clinician AI scribe): Individual clinician plans publicly start at $39/month, Core is $79/month, Premier is $104/month, and Groups are custom. Implication: Do not price SCRIMED like a single-seat scribe; use those prices as a floor for narrow clinician utility and keep SCRIMED positioned around enterprise governance, workflow proof, interoperability, and buyer diligence. Source: https://www.getfreed.ai/pricing
- Tali (AI scribe and clinical assistant): Free tier, paid clinician tiers around CA $50 to CA $150/month, and enterprise custom pricing for multi-clinician organizations. Implication: Keep public demos free and frictionless, but route organization-level proof, analytics, custom packets, governance, and onboarding into paid assessment or pilot scope. Source: https://tali.ai/pricing
- Heidi Health (AI scribe, evidence, and enterprise practice plans): Public plan architecture includes Free, Evidence Plus, Clinician, and Practice plans with team, EHR integration, SSO, service availability, and custom hosting features in higher tiers. Implication: SCRIMED should preserve a free public product preview while making enterprise controls, evidence rooms, and protected work explicitly sales-led. Source: https://www.heidihealth.com/pricing
- Suki (End-to-end AI assistant for clinicians): Enterprise-oriented pricing is sales-led; public product copy spans pre-visit, encounter, post-visit, EHR delivery, order staging, coding, and multilingual instructions. Implication: SCRIMED should price pilots by workflow family, governance burden, proof depth, and connector/readiness complexity rather than by seat alone. Source: https://www.suki.ai/clinicians/
- Ambience Healthcare (Enterprise documentation, coding, and revenue integrity platform): Sales-led enterprise motion with published outcome claims around utilization, charting time, coding, EHR integration, and revenue integrity. Implication: SCRIMED can command enterprise pricing only when claims stay evidence-backed, buyer-permitted, and scoped to no-PHI pilots until clinical production gates are complete. Source: https://www.ambiencehealthcare.com/
- Redox (Healthcare data integration infrastructure): Custom pricing for healthcare integration needs, with scale signals around transactions, connected organizations, uptime, EHR connections, HITRUST, and SOC 2. Implication: Keep SCRIMED connector, data exchange, and production integration work out of standard pilot fees until separately reviewed and priced. Source: https://redoxengine.com/
- Berta open-source scribe deployment (Health-system-owned AI documentation infrastructure): The 2026 arXiv paper reports commercial AI scribes at $99-$600 per physician per month and an internal operating-cost benchmark below $30 per physician per month. Implication: SCRIMED must defend price through enterprise operating value: proof, governance, workflow redesign, interoperability readiness, safety controls, and margin-transparent implementation. Source: https://arxiv.org/abs/2603.23513

## Hard Stops
- Do not accept PHI, patient identifiers, payer member identifiers, production credentials, secrets, or live records in demo or pilot intake.
- Do not quote custom SOWs, implementation work, connector work, security questionnaire labor, or evidence-room release without package selection and human deal review.
- Do not benchmark SCRIMED against low monthly AI-scribe seats as if SCRIMED were only documentation automation.
- Do not imply guaranteed ROI, revenue lift, reimbursement, clinical outcome improvement, customer permission, certification, production readiness, or legal approval.
- Do not open protected workspace evidence externally without AAL2 controls, release decision, recipient rules, and customer permission path.

## Next Actions
- Make /pilot-demo-commercial-readiness the internal and buyer-safe command page before demos or pilot calls.
- Start every buyer call with the closest demo path and end with one recommended package, price band, proof asset list, and no-PHI intake route.
- Use updated ranges as floors unless finance, legal, and founder review approve scope reduction.
- Route any custom proof, questionnaire, security review, or executive packet work into paid diligence or Enterprise Proof and Deal Room Activation.
- Keep enterprise license pricing separate from services, connectors, support, usage, and continuous review retainers.